Patent Application
20120271141
The present invention relates generally to the measurement or detection of electrical signals such as in abnormal or cancerous tissue, and more particularly, to the detection of changes in the electrophysiological characteristics of abnormal or cancerous tissue and to changes in those electrophysiological characteristics related to the functional, structural and topographic (the interaction of shape, position and function) relationships of the tissue during the development of malignancy. Measurements can be made in the absence or presence of pharmacological, hormonal or other chemical agents to reveal and accentuate the electrophysiological characteristics of abnormal or cancerous tissue.
Difficulty in detecting abnormal pre-cancerous or cancerous tissue before treatment options become non-viable is one of the reasons for the high mortality rate from cancer. Detecting the presence of abnormal or cancerous tissues is difficult, particularly where affected tissues are located beneath the skin surface, for example, deep within the body, thus requiring expensive, complex, invasive, and/or uncomfortable procedures. Thus, the use of detection procedures is often restricted or delayed until a patient experiences symptoms related to abnormal tissue. Many forms of cancers or tumors, however, require extended periods of time to attain a detectable size and thus to produce significant symptoms or indicate their presence in the patient. It is often too late for effective treatment by the time detection is performed with currently available diagnostic modalities.
Breast cancer is the most common malignancy affecting women in the Western World. The reduction in mortality for this widespread disease depends in significant part on early detection. The mainstay of early detection is X-ray mammography and clinical breast examination. Both are fraught with difficulties, including inaccuracy. For example, mammography has a lower sensitivity in women with dense breasts, and it is also unable to satisfactorily discriminate between morphologically similar benign and malignant breast tissue.
Clinical breast examinations are limited because lesions less than one centimeter are usually undetectable and larger lesions may be obscured by diffuse nodularity, fibrocystic change, or may be too deep in the breast to enable such clinical detection. Patients with positive mammographic or equivocal clinical findings often require biopsy to make a definitive diagnosis.
Accordingly, in view of the relatively poor specificity in diagnosing breast cancer, mammography and clinical breast examination can result in many positive mammographic findings or lesions detected on clinical breast examination which ultimately prove to be false positives, resulting in physical and emotional trauma for patients. Improved methods and technologies to accurately detect lesions and/or to identify patients who may need to undergo an invasive biopsy would reduce healthcare costs and avoid unnecessary diagnostic biopsies.
In a first embodiment, an apparatus for detecting electrophysiological characteristics in tissue may include a cup having a concave shape and adapted to be positioned on epithelial tissue, the cup capable of maintaining a reduced air pressure and holding a volume of flowable material; and an electrical support structure comprising a support structure and a plurality of sensors, electrodes, or both configured to interact with epithelial and subepithelial tissue.
In another embodiment, an apparatus for determining electrophysiological characteristics of subepithelial tissue, the apparatus comprising a cup adapted to contact epithelial tissue comprising a surface having a concave shape, having a volume enclosed by the cup and the epithelial tissue, the cup capable of maintaining a reduced air pressure and holding a volume of flowable material; and an electrical support structure comprising a connection between an instrument for measuring or recording electrical signals and a plurality of sensors, electrodes or both configured to interact with the epithelial and subepithelial tissue. The apparatus may further include an at least one port, and a reservoir comprising a volume of flowable material, in connection with a first port through which at least a portion of the flowable material may be transferred to the volume of the cup; an overflow reservoir; and a valve positioned on a path between the cup and the overflow reservoir for facilitating, maintaining or both, a reduced air pressure within the volume of the cup.
In yet another embodiment, an apparatus for detecting electrophysiological characteristics in breast tissue, the apparatus comprising a cup having a concave shape and adapted to be positioned over an area immediately surrounding a nipple of the breast, the cup capable of maintaining a reduced air pressure and holding a volume of flowable material within a volume defined by the concave shape of the cup and an area immediately surrounding the nipple; a reservoir, integral with the cup, comprising a volume of flowable material, the reservoir adapted to connect with the volume of the cup through a port through which at least a portion of the volume of flowable material may be transferred to the volume of the cup; an instrument for measuring or recording electrical signals; and a plurality of electrodes, sensors or both attachably configured in, on or adjacent to the cup, adapted to interact with the nipple and ductal and epithelial tissue of the breast.
In a further embodiment, an apparatus for detecting electrophysiological characteristics in subepithelial tissue, the apparatus comprising a cup adapted to contact epithelial tissue comprising a surface having a concave shape, having a volume enclosed by the cup and the epithelial tissue capable of both maintaining a reduced air pressure and holding a flowable material, and at least one port; a plurality of sensors attachably configured on and adjacent to the cup to contact the epithelial tissue and interact with the ductal epithelial tissue, subepithelial tissue and other deep tissue.
In an alternate embodiment, the apparatus may further include at least a second port associated with the cup. Alternatively, the apparatus may include a puncture seal comprising a portion of the surface of the cup. Alternatively, the apparatus may include a pump in connection with the reservoir to transfer at least a portion of the flowable material to the volume of the cup. Moreover, the cup may be deformable upon the generation of the reduced air pressure or upon application of pressure to an outer surface of the concave shape.
In yet a further embodiment, the present invention may include a method of detecting electrophysiological characteristics in subepithelial tissue, the method comprising contacting epithelial tissue with an apparatus comprising a cup having a concave shape and adapted to be positioned on epithelial tissue, the cup capable of maintaining a reduced air pressure and holding a volume of flowable material, and an electrical support structure comprising a support structure and a plurality of sensors, electrodes, or both configured to interact with epithelial and subepithelial tissue; and connecting the apparatus to an instrument for measuring or recording electrical signals from the apparatus.
In certain embodiments, the flowable material and/or the electrical support structure may be altered or changed to detect electrophysiological changes in the subepithelial tissue.
a and 4b illustrate various embodiments of electrical support structures of the apparatus.
Reference will now be made in detail to an embodiment of the invention, examples of which are illustrated in the accompanying drawings.
The present invention overcomes deficiencies associated with prior devices. In a first embodiment, as exemplified in
As illustrated in
The fill port 17, as exemplified in
The electrical support structure 14 may, in one embodiment, as exemplified in
The plurality of sensors 15, 215, illustrated for example on
The sensors 15, 215 should be placed on the arms, or the like, at various distances from the cup 12 depending on the area to be tested. In one example, when testing the breast, the sensors 15 may be located up to about 8 to about 10 cm from the cup 12 in order to test a significant portion or substantially the entire breast, although at least one sensor 15, 215 should be placed within the cup 12 to send and/or receive electrical signals directly through the nipple, affiliated ductal tissue of the nipple, and/or other tissue positioned within the cup 12. Of course, if the support structure 514 of
The sensor 15 positioned within the cup 12 may not physically contact the nipple, however, and may be positioned in the cup 12 such that the sensor 15 only contacts the flowable material and not the nipple tissue itself. The electrical support structure 14, 214 may further include an adhesive film or foam 60, or the like to promote adherence of support structure 14, 214 to the skin. Other alternative arrangements may be used, such as the portion of the support structure 14, 214 within or near cup 12 may have the adhesive film or foam 60, while the out-lying portions of support structure 14 may use tape or a different adhesive. Similarly, support structure 314, 414, 514 may utilize such adhesive films, foams or other substances over at least a portion of the circular, ellipsoid, or annular surface, or the surface of the ends of the elongated arms, including any area adjacent the cup 312, 412 to promote adhering contact between cup 312, 412 and support structure 314, 414. Each sensor 215 may be connected by wire connections 265, as illustrated in
While
The plurality of sensors 115, as illustrated in
The various embodiments illustrated in
In operation, the apparatus 10, 110 (hereinafter, for simplicity, the embodiment of
One example of an method of use of apparatus 10 may include the placement of the cup 12 over a nipple such that the nipple is positioned within volume 50. Cup 12 may form an airtight (or substantially airtight during the test period) connection with the nipple and the remaining volume 50 may be filled with a flowable material (not shown). Adhesive film or foam 160 (
The flowable material may be any suitable material capable of conducting an electrical current, and may include liquids, gels or the like. As used in this description, a flowable material may be a medium that permits transmission of electrical signals between the surface being measured and the sensors 15, 215, particularly those positioned inside the volume 50 of cup 12. The material may further include any ionic concentration, pharmacological agent, hormone or other compound added to the material or otherwise introduced to the tissue under investigation, selected to provide further information about the condition of the tissue, if desired. In another embodiment the concentrations of agents may be changed using a flow through system. In addition, the impedance at varying subepithelial tissue depths and responses of, for example, DC potential and/or impedance to different concentrations of ions, drug, hormones, or other agent may be used to estimate the probability of cancerous tissue being present.
Flowable materials for use with the present inventions could include various electrolyte solutions such as physiologic saline (e.g. Ringers) with or without pharmacological agents. One preferable electrolyte solution to infuse into the ductal system will represent a physiological Ringer solution. Typically this consists of NaCl 6 g/L, KCl 0.075 g/L, CaCl2 0.1 g/L, NaHCO3 0.1 g/L, and smaller concentrations of sodium hyper and hypophosphate at a physiological pH of 7.4. Other electrolyte solutions may be used where the electrolyte comprises approximately 1% of the volume of the solution. Hypertonic or hypotonic solutions that are greater or less than 1% may be used in provocative testing of the epithelium and/or tumor. The concentration of Na, K and Cl will be adjusted under different conditions to evaluate the conductance and permeability of the epithelium. Different pharmacological agents such as amiloride (to block electrogenic sodium absorption), Forskolin (or similar drugs to raise cyclic-AMP) and hormones such as prolactin or estradiol can also be infused with the Ringer solution to examine the electrophysiological response of the epithelium and tumor to these agents. Similarly, the calcium concentration of the infusate will be varied to alter the tight junction permeability and measure the electrophysiological response of the epithelium to such manipulation. Dexamethasone may be infused to decrease the permeability of the tight junctions, and the electrophysiological response will be measured. In a further embodiment, the flowable material may be an electroconductive fluid or gel. In one example, the flowable material may be physiological saline, such as Normosol™ (Hospira Inc., Lake Forest, Ill.), which is a sterile, nonpyrogenic, isotonic solution of balanced electrolytes in water. Suitable electrolytes may include sodium chloride, sodium acetate, sodium gluconate, potassium chloride, magnesium chloride, or the like or any combination thereof. The flowable material may then provide a medium for application of a reduced air pressure within the cup and/or electrical contact to the nipple, which will be further explained below.
In another embodiment, the flowable material may be an electroconductive media which may include conductive fluids, creams or gels used with external or internal electrodes to reduce the impedance (resistance to alternating current) of the contact between the sensor 15 and the skin or epithelial surface. In the case of DC sensors it is also desirable that the flowable material results in the lowest DC offset at the sensor surface, or an offset that can be measured. The flowable material will often contain a hydrogel that will draw fluid and electrolytes from deeper layers of the skin to establish electrical contact with the sensor 15. Sensors that are used to pass current require flowable materials with high conductance. Usually this is accomplished by using flowable materials with high electrolyte content. The electrolytes frequently used are KCl (potassium chloride) because of the similar ionic mobility of these two ions in free solution, so that sensor polarization is less of a problem than when ions of different mobility are used. Other ions such as sodium may be used in flowable material formulations, and the higher electrolyte concentrations result in more rapid sensor equilibration. Such various types of flowable materials, particularly those including a chemical agent, are capable of effecting a physiological response in the subepithelial tissue, wherein the chemical agent may include a defined ionic concentration, a pharmacological agent, a hormone, or any combination thereof. Such various flowable materials may be used to provide various data wherein various flowable materials having different properties are used in series (one after another) to detect electrophysiological changes in the subepithelial tissue.
In situations where estimations will be made of the permeability of the epithelium to specific ions, the concentration of K (potassium) in the flowable material will be varied so that the conductance of the epithelium to potassium may be measured electrophysiologically. An enhancer or permeant may be added to the flowable material to increase the conductance of the underlying skin to the electrolyte in the flowable material. Other approaches to improving electrical contact and/or reducing surface skin impedance include mild surface abrasion with pumice and alcohol to reduce surface skin resistance, abrasive pads such as Kendall Excel electrode release liner (Tyco Health Care, Mansfield, Ma.), 3M Red Dot Trace Prep (3M Corporation, St. Paul, Minn.), cleaning the skin with alcohol, an automated skin abrasion preparation device that spins a disposable electrode to abrade the skin (QuickPrep system, Quinton, Inc., Bothell, Wash.), the use of ultrasound skin permeation technology (SonoPrep, Sontra Medical Corporation, Franklin, Mass.; U.S. Pat. No. 6,887,239, Elstrom et al.), or silicon microneedle array electrodes, which just reach, or may even penetrate, the stratum corneum to reduce skin surface resistance. (See, for example, P. Griss et al., IEEE Trans. on Biomedical Eng., 2002, 49 (6), 597-604) (For a comparison and discussion of several methods see also, Biomedical Instrumentation & Technology, 2006; 39: 72-77. The content of the patent and journal documents are incorporated herein by reference.) For example, microneedle electrodes, also known as spiked electrodes, may be used on any of the sensors 15, but will be most useful when used as a sensor 15 on at least one location on at least one arm of the support structure 14. In one configuration, each arm will include at least one microneedle electrode. The microneedle electrodes include nano-sized needles on the tissue-contacting surface of the electrode which are conductive and may penetrate the stratum corneum and enter into the viable epidermis. They are typically sized from about 15 um to about 200 um in length, and more specifically about 30 um to about 50 um, about 30 um in width, and may be made of metal, coated silicon or coated plastic. An electrode may typically have about 100 to about 10,000 microneedles on its tissue-contacting surface. Microneedle electrodes are described in the following U.S. Patent references: U.S. Pat. No. 6,622,035; 2007/0135729; 2004/0167422; U.S. Pat. No. 7,032,301 and PCT Application WO07/068433, all of which are incorporated by reference herein.
Although specific examples have been given of drugs and hormones that may be used in “challenge” testing of the epithelium, subepithelium and tumor, any agonist or antagonist of specific ionic transport, or tight-junctional integrity, known to be affected during carcinogenesis may be implemented, particularly when it is known to influence the electrophysiological properties of the epithelium, subepithelium or tumor.
As alluded to above, prior to the passage of the flowable material into the volume 50, the electrical support structure 14, including the plurality of sensors 15, may also be connected to the surrounding tissue (typically epithelial tissue or skin) around or in proximity to the nipple. The electrical support structure may be flexible, to conform to the surrounding tissue, and may have an underside which secures attachment to the tissue surrounding the nipple, which may be an adhesive, an adhesive film or foam 160 (
As the flowable material is pumped into the volume 50, air may be pushed out of the volume 50 through exhaust port 20, one-way valve 22 and out air exit port 25. A reduced air pressure, within volume 50, may be created, using the pump, for example, to draw the nipple further into the volume 50 while removing air from the volume 50. The “reduced air pressure,” formed within volume 50, may have an air pressure that is less than ambient air pressure. For example, the reduced air pressure may be a partial vacuum of any pressure below ambient pressure or a substantially complete vacuum. The reduced air pressure may be created, for example, through a short series of suction and release actions using the pump to draw a portion of the flowable material back into reservoir 16, although other methods may be used to create the reduced air pressure. For example, the reduced air pressure may have a pressure of about 100 mm Hg, which typically coincides with roughly 5 mL of flowable material pumped back out of volume 50 and into reservoir 16. Then, about 3 mL of flowable material may be pumped back into volume 50 to lower the pressure to about 20 mm Hg. This back-and-forth process may be repeated multiple times to remove air bubbles from volume 50, raise the nipple further into cup 12, and the like. Any air remaining in the volume 50 may be collected within the domed tip of the cup 12, and may be removed by use of a syringe, a duct, a valve, or the like.
The one-way valve 22 may assist in forming the reduced air pressure by allowing air to pass through exhaust port 20 and into exhaust reservoir 24, but preventing air to pass from the reservoir 24 and back into volume 50 through exhaust port 20. In this respect, one-way valve 22 may be a check valve or other structure of similar use. Moreover, exhaust reservoir 24 may be a smaller volume than reservoir 16, for example about 5 mL, and may be used to hold any flowable material which passes through exhaust port 20 during the filling and/or reduced air pressure processes, or at any other time. Any volume of air and/or flowable material which passes through exhaust port 20 in excess of the volume of exhaust reservoir 24 may pass through air exit port 25. However, air exit port 25 should be positioned on the exhaust reservoir 24 such that, under normal circumstances, excess flowable material remains within exhaust reservoir 24 and cannot leak out of air exit port 25, but the air removed from the volume 50 may still be released, if required.
The reduced air pressure provides numerous benefits including that the air is substantially or completely out of volume 50, that the flowable material takes up substantially or entirely the remaining volume 50 that is not taken up by the nipple, and that the cup 12 is secured to the tissue, among other reasons. In one example, the cup 12, once the reduced air pressure is applied, will have about 10 mL of volume which the flowable material can occupy.
With the cup 12 placed in this position, the plurality of sensors 15, attached to the electrical support structure 14 which is attached to the bottom of cup 12 as in
Once the reduced air pressure is obtained and stabilized, the control instrument may supply electrical signals through the plurality of sensors 15. The electrical signals pass through the sensors 15 and into the surface tissue, whether the nipple via the flowable material, the surrounding epithelial tissue, or both. The sensors 15 may then gather data of the deep tissue below the surface tissue (such as the subepithelial tissue, epithelial ductal tissue, or the like) which is obtained by passing the electrical signals through the surface tissue and into the deep tissue. The sensors 15 may pass the data back to the control instrument which may analyze the data or pass it to a further machine capable of processing and analyzing the data. The electrical signals may conduct tests and acquire data anywhere a sensor 15 is placed. For example, in
In one embodiment of the use of apparatus 10, 110, the sensors 15, 115, 215 may receive various electrical signals from the control instrument. The sensors 15, 115, 215 located on the arms of the electronic support structure 14, 214 are connected to a frequency response analyzer (FRA) which may be interfaced with the patient through a biological impedance isolator. A sine wave at one or more selected frequencies, for example, about 50 Hz or about 60 Hz may then be passed between the sensors 15, 115, 215 on the cup 12, 112 (connected to the nipple through the flowable material) and the outermost sensors 15, 115, 215 on the arms at each quadrant of the breast which may be located roughly 8-10 cm from the cup 12, 112. The impedance may then be measured in a sequential manner between the sensors 15, 115, 215 on cup 12, 112 and the outermost sensors 15, 115, 215 at each quadrant of the breast. This measurement may then be used to obtain the average tissue density of the four quadrants of the breast using the methods as disclosed in U.S. Ser. No. 12/316,032, incorporated herein by reference. This test may be replicated as many times as necessary and at other frequencies (e.g., about 10 Hz, about 100 Hz, about 1,000 Hz, about 10,000 Hz, using DC or the like). The sensors 15, 115, 215 on the arms may also be at various distances from the cup 12, 112 to obtain readings all along each quadrant (e.g., sensors may be at about 4 cm, 7 cm, 8 cm, 10 cm, etc.). In one method of using the apparatus, the operator may use various electrical connections having different properties, used in series (one after the other), to detect electrophysiological changes in the subepithelial tissue including altering the voltage, current, location of sensors, or any combination thereof. The density readings, for example, are then compared and the presence of pre-cancerous or cancerous tissue may be illustrated by a different reading of tissue characteristics, correlated with, for example, density in one quadrant, for example, than in the other quadrants or from a previous or expected value for a patient.
Once the test is complete whereby the electrical signals and data collection are completed, the operator may puncture the puncture seal 21 to release the reduced air pressure and empty the volume 50 of the flowable material. Puncture seal 21 may be punctured with a built-in mechanism or a hand-held object, such as a pin, knife, scalpel, or the like. The flowable material may then empty directly out of the puncture seal 21 or may pass back through to the reservoir 16. Alternatively, the pump may be used to increase pressure in the cup 12, to force the flowable material from the cup. Alternatively, the puncture seal 21 may be another structure, such as a rubber stop, valve, gate, or the like.
This use may be conducted on only a single breast/nipple or may be done on both breasts/nipples.
The apparatus 10, 110 may include other elements in addition to those discussed above. For example, various elements of apparatus 10, 110 may be made of different materials. Cup 12, 112 may be of a clear polymer or plastic to enable the operator to view inside the cup 12, 112 during the test. Either or both of the reservoirs may also be of a clear polymer plastic to enable viewing of the flowable material. Furthermore, the electrical support structures 14, 114, 214 may be made of polymer plastic which may be flexible to allow it to conform to the tissue, deform under pressure of the reduced air pressure and/or deform under application of pressure by the user to the outer surface of the concave shape of cup 12. Likewise, electrical support structure 14, 114, 214 can be similar to a tape having an adhesive underside. Other materials may also be used which are suitable for the purposes and uses discussed herein.
Apparatus 10, 110 may be disposable, or at least a portion may be disposable, or may be nondisposable and reusable. If apparatus 10, 110 is disposable, then puncture seal 21 may be constructed to be irreversibly breakable and flowable material may flow out of apparatus 10, 110. Apparatus 10, 110 may further be of a one-piece, two-piece or multiple piece design. Apparatus 10, 110 may then be removed from the tissue and disposed. If apparatus 10, 110 has only a disposable cup 12, then the seal may or may not be irreversibly breakable, and flowable material may either flow out of apparatus 10, 110 or back into reservoir 16 for later repeated use. In this embodiment, the cup 12 (
Although the invention herein has been described with reference to particular embodiments, it is to be understood that these embodiments are merely illustrative of the principles and applications of the present invention. It is therefore to be understood that numerous modifications may be made to the illustrative embodiments and that other arrangements may be devised without departing from the spirit and scope of the present invention as defined by the appended claim.
The present application claims the benefit of Application Ser. No. 61/279,471, filed Oct. 21, 2009, entitled SKIN SURFACE ELECTORDES, the disclosure of which is hereby incorporated herein by reference.
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/US2010/053015 | 10/18/2010 | WO | 00 | 6/7/2012 |
| Number | Date | Country | |
|---|---|---|---|
| 61279471 | Oct 2009 | US |
